Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Abstract Background Treatment for non-small cell lung cancer (NSCLC) has greatly improved in recent years. However, noninvasive early screening for carcinogenesis and progression unclear. The aim of this study was to explore the predictive value of peripheral blood immune cells in untreated NSCLC pa...

Full description

Bibliographic Details
Main Authors: Yingyi Wang, Na Zhou, Rui Zhu, Xiaoyuan Li, Zhao Sun, Yang Gao, Wei Liu, Changting Meng, Yuping Ge, Chunmei Bai, Taisheng Li, Hongsheng Liu
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Pulmonary Medicine
Subjects:
Immune cells
NSCLC
Cancer occurrence
Advance cancer stage
Clinicopathologic characteristics
Online Access:https://doi.org/10.1186/s12890-021-01636-x

Internet

https://doi.org/10.1186/s12890-021-01636-x

Similar Items